BX-471(ZK 811752)
产品编号: DC7675
Featured
我们的合作伙伴:
中国地区超过5000个高品质化合物库存
应用领域
BX471 (ZK-811752) 是以一种口服有效的,选择性,非多肽的 CCR1 拮抗剂,Ki 值为 1 nM,对其选择性是对 CCR2,CCR5 和 CXCR4 的 250 倍。
Cas No.: |
217645-70-0 |
名称: |
(2R)-1-[[2-[(Aminocarbonyl)amino]-4-chlorophenoxy]acetyl]-4-[(4-fluorophenyl)methyl]-2-methylpiperazine |
别名: |
ZK 811752,ZK811752,ZK-811752,BX-471; BX 471,BX-471 |
SMILES: |
C[C@@H]1CN(CCN1C(=O)COC2=C(C=C(C=C2)Cl)NC(=O)N)CC3=CC=C(C=C3)F |
分子式: |
C21H24ClFN4O3 |
分子量: |
434.89 |
纯度: |
|
保存条件: |
2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: |
|
In Vivo: |
|
In Vitro: |
|
References: |
BX471 is a potent, selective non-peptide CCR1 antagonist (Ki = 1 nM For human CCR1); exhibits 250-fold selectivity For CCR1 over CCR2, CCR5 and CXCR4.
IC50 value: 1 nM(Ki)
Target: CCR1
BX471 inhibits MIP-α/CCL3-induced intracellular Ca2+ mobilization. |
Kinase Assay: |
|
Cell Assay: |
|
Animal Administration: |
|
References: |
|
MSDS
COA
LOT NO. |
DOWNLOAD |
|
|
2018-0101 |
|
询盘